Published in Am J Cardiol on March 01, 2004
Redox control of renal function and hypertension. Antioxid Redox Signal (2008) 1.45
Salivary Stress-Related Responses in Tinnitus: A Preliminary Study in Young Male Subjects with Tinnitus. Front Neurosci (2016) 0.79
Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study. Immun Ageing (2016) 0.75
Increased plasma neopterin levels are associated with reduced endothelial function and arterial elasticity in hypertension. J Hum Hypertens (2015) 0.75
The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents. J Clin Diagn Res (2013) 0.75
Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection. Circulation (2002) 2.73
Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries. Circulation (2014) 2.65
Total cholesterol content of erythrocyte membranes is increased in patients with acute coronary syndrome: a new marker of clinical instability? J Am Coll Cardiol (2007) 2.56
High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circ Res (2012) 2.26
High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries. The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries). J Am Coll Cardiol (2012) 2.24
[Corrected QT interval prolongation: a new predictor of cardiovascular risk in patients with non-ST-elevation acute coronary syndrome]. Rev Esp Cardiol (2008) 2.06
Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol (2004) 2.00
Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med (2010) 1.89
Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk. Atherosclerosis (2008) 1.76
Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation (2003) 1.68
Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis (2011) 1.63
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris. Eur Heart J (2005) 1.58
Cystatin C and cardiovascular risk. Clin Chem (2009) 1.57
Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol (2003) 1.56
Pharmacological treatment of chronic stable angina pectoris. Clin Med (2013) 1.51
Fear of dying and inflammation following acute coronary syndrome. Eur Heart J (2011) 1.50
Interleukin-8 is increased in the membrane of circulating erythrocytes in patients with acute coronary syndrome. Eur Heart J (2008) 1.48
New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv (2010) 1.46
Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. Circulation (2004) 1.45
Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X). Cardiovasc Drugs Ther (2012) 1.43
Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction. Thromb Res (2007) 1.43
Alteplase treatment affects circulating matrix metalloproteinase concentrations in patients with ST segment elevation acute myocardial infarction. Thromb Res (2005) 1.40
[Impact of blood pressure control on the ankle-brachial index in hypertensive patients]. Med Clin (Barc) (2012) 1.38
C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J (2004) 1.35
C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol (2003) 1.24
Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X. Eur Heart J (2003) 1.23
Neurocognitive function and cerebral emboli: randomized study of on-pump versus off-pump coronary artery bypass surgery. Ann Thorac Surg (2007) 1.18
Microvascular dysfunction in cardiac syndrome X: the role of inflammation. CMAJ (2006) 1.15
Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation (2004) 1.14
Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol (2004) 1.09
Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J (2012) 1.07
Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis (2011) 1.05
Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations. Atherosclerosis (2009) 1.04
Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis (2004) 1.04
Pulse pressure and progression of chronic kidney disease. J Nephrol (2010) 1.03
Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol (2005) 1.02
Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity? Nat Clin Pract Cardiovasc Med (2008) 1.02
Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol (2006) 1.01
A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res (2008) 0.98
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging (2013) 0.97
Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J (2005) 0.97
Epidemiology of the diabetic heart. Coron Artery Dis (2005) 0.97
Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol (2003) 0.97
Myocardial infarction in the elderly. Aging Dis (2010) 0.96
Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation (2004) 0.96
Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach. Atherosclerosis (2006) 0.96
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res (2008) 0.95
Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem (2004) 0.93
Relation of circulating C-reactive protein to progression of aortic valve stenosis. Am J Cardiol (2005) 0.93
Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis (2008) 0.91
Neutrophil count and infarct size in patients with acute myocardial infarction. Int J Cardiol (2004) 0.90
Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with ST-segment elevation myocardial infarction. Am J Cardiol (2005) 0.90
Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol (2004) 0.90
Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean patients with non-ST elevation acute coronary syndrome. Atherosclerosis (2009) 0.89
Atherosclerotic plaque regression: fact or fiction? Cardiovasc Drugs Ther (2010) 0.89
Pseudoaneurysm complicating aortic coarctation in a pregnant woman. Int J Cardiol (2004) 0.88
Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis (2007) 0.88
S100 protein and its relation to cerebral microemboli in on-pump and off-pump coronary artery bypass surgery. Eur J Cardiothorac Surg (2004) 0.87
Interleukin-18: interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome. Atherosclerosis (2005) 0.87
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens (2009) 0.87
C-reactive protein improves risk prediction in patients with acute coronary syndrome, or does it? Eur Heart J (2009) 0.86
Independent and additive predictive value of total cholesterol content of erythrocyte membranes with regard to coronary artery disease clinical presentation. Int J Cardiol (2010) 0.85
Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. J Nephrol (2010) 0.85
N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction. Am J Cardiol (2005) 0.85
Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels (2008) 0.85
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol (2009) 0.84
Complete regression of cardiac non-Hodgkin lymphoma. Int J Cardiol (2006) 0.84
Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol (2004) 0.84
A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome. Int J Cardiol (2005) 0.84
The Who, What, Why, When, How and Where of Vasospastic Angina. Circ J (2015) 0.84
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) (2012) 0.83
Anti-inflammatory effects of ivabradine in patients with acute coronary syndrome: a pilot study. Int J Cardiol (2012) 0.83
Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitus. Am J Cardiovasc Drugs (2006) 0.83
Statin use is associated with a significant reduction in cholesterol content of erythrocyte membranes. A novel pleiotropic effect? Cardiovasc Drugs Ther (2009) 0.83
Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the If current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome--RIVIERA trial study design and rationale. Cardiovasc Drugs Ther (2009) 0.83
Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther (2009) 0.83
Pregnancy-associated plasma protein A: Has this biomarker crossed the boundary from research to clinical practice? Drug News Perspect (2009) 0.83
Burden of systemic hypertension in patients admitted to cardiology hospitalization units. Am J Cardiol (2011) 0.83
Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Am J Cardiol (2008) 0.82
[Interleukin-10 and coronary disease]. Rev Esp Cardiol (2002) 0.82
Decreased levels of alternative co-stimulatory receptors OX40 and 4-1BB characterise T cells from head and neck cancer patients. Immunobiology (2011) 0.82
Noninvasive assessment of endothelial function in clinical practice. Rev Esp Cardiol (Engl Ed) (2011) 0.82
Interleukin-18/interleukin-10 ratio is an independent predictor of recurrent coronary events during a 1-year follow-up in patients with acute coronary syndrome. Int J Cardiol (2006) 0.82